Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Diabetes affects an estimated 415 million people worldwide, with type 2 diabetes (T2D) accounting for about 90% of these ...

Developing regions such as Sub-Saharan Africa, Latin America, and the Caribbean showed particularly alarming numbers ...

A new review found as many as 45% of Type 2 diabetics are suffering multiple deficiencies in vitamins, minerals and ...

As part of our Masterclass series, GP specialist in diabetes Dr Elizabeth Martin explains the key points in prevention, ...

Micronutrient deficiencies, such as low vitamin D and magnesium, are alarmingly common in people with type 2 diabetes, ...

A new study analyzed data from 2.9 million individuals across 118 countries and found that consumption of sugar-sweetened ...

Globally, the burden of sugar-sweetened beverage consumption was found to be greater among men than women, as well as among ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing kidney failure risk, disease progression, and death due to ...